Dennis M Fenton - Net Worth and Insider Trading
Dennis M Fenton Net Worth
The estimated net worth of Dennis M Fenton is at least $40 Million dollars as of 2024-09-20. Dennis M Fenton is the Executive V.P., Operations of Amgen Inc and owns about 117,518 shares of Amgen Inc (AMGN) stock worth over $40 Million. Dennis M Fenton is the Director of XenoPort Inc and owns about 14,300 shares of XenoPort Inc (XNPT) stock worth over $101,101. Dennis M Fenton is also the Director of AnaptysBio Inc and owns about 1,950 shares of AnaptysBio Inc (ANAB) stock worth over $75,407. Besides these, Dennis M Fenton also holds Sienna Biopharmaceuticals Inc (SNNAQ) . Details can be seen in Dennis M Fenton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennis M Fenton has not made any transactions after 2024-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dennis M Fenton
Dennis M Fenton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis M Fenton owns 6 companies in total, including Portola Pharmaceuticals Inc (PTLA) , AnaptysBio Inc (ANAB) , and Sienna Biopharmaceuticals Inc (SNNAQ) among others .
Click here to see the complete history of Dennis M Fenton’s form 4 insider trades.
Insider Ownership Summary of Dennis M Fenton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTLA | Portola Pharmaceuticals Inc | 2020-07-02 | director |
| ANAB | AnaptysBio Inc | 2024-06-21 | director |
| SNNAQ | Sienna Biopharmaceuticals Inc | 2019-05-30 | director |
 | | 2017-05-05 | director |
| | 2016-07-05 | director |
| | 2007-06-04 | Executive Vice President |
Dennis M Fenton Latest Holdings Summary
Dennis M Fenton currently owns a total of 4 stocks. Among these stocks, Dennis M Fenton owns 117,518 shares of Amgen Inc (AMGN) as of June 4, 2007, with a value of $40 Million and a weighting of 99.56%. Dennis M Fenton owns 14,300 shares of XenoPort Inc (XNPT) as of May 27, 2014, with a value of $101,101 and a weighting of 0.25%. Dennis M Fenton also owns 1,950 shares of AnaptysBio Inc (ANAB) as of June 21, 2024, with a value of $75,407 and a weighting of 0.19%. The other 1 stocks Sienna Biopharmaceuticals Inc (SNNAQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Dennis M Fenton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMGN | Amgen Inc | 2007-06-04 | 117,518 | 336.60 | 39,556,559 |
| XNPT | XenoPort Inc | 2014-05-27 | 14,300 | 7.07 | 101,101 |
| ANAB | AnaptysBio Inc | 2024-06-21 | 1,950 | 38.67 | 75,407 |
| SNNAQ | Sienna Biopharmaceuticals Inc | 2017-09-18 | 1,250 | 0.00 | 0 |
Holding Weightings of Dennis M Fenton
Dennis M Fenton Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis M Fenton has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 15,143 shares on June 4, 2007, which brought Dennis M Fenton around $858,911.
According to the SEC Form 4 filings, Dennis M Fenton has made a total of 0 transactions in XenoPort Inc (XNPT) over the past 5 years. The most-recent trade in XenoPort Inc is the acquisition of 3,000 shares on May 27, 2014, which cost Dennis M Fenton around $12,060.
According to the SEC Form 4 filings, Dennis M Fenton has made a total of 1 transactions in AnaptysBio Inc (ANAB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in AnaptysBio Inc is the sale of 1,950 shares on June 21, 2024, which brought Dennis M Fenton around $45,182.
More details on Dennis M Fenton's insider transactions can be found in the Insider Trading History of Dennis M Fenton table.Insider Trading History of Dennis M Fenton
- 1
Dennis M Fenton Trading Performance
GuruFocus tracks the stock performance after each of Dennis M Fenton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennis M Fenton is 11.17%. GuruFocus also compares Dennis M Fenton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennis M Fenton within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dennis M Fenton's insider trading performs compared to the benchmark.
Performance of Dennis M Fenton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.52 | | | | | |
| Relative Return to S&P 500(%) | 1.76 | | | | | |
Dennis M Fenton Ownership Network
Dennis M Fenton Owned Company Details
What does Portola Pharmaceuticals Inc do?
Who are the key executives at Portola Pharmaceuticals Inc?
Dennis M Fenton is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .
Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Portola Pharmaceuticals Inc Insider Transactions
Dennis M Fenton Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis M Fenton. Currently GuruFocus does not have mailing address information for Dennis M Fenton.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
